Our results suggested that culture CD13+CD133+EpCAM+ HCC cells with modified CDM could effectively maintain a high level of expression of CD13 and EpCAM in terms of both expression proportion and MFI. This evidence concerns the gene EPCAM and hepatocellular carcinoma.